Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Oral STIs include chlamydia, gonorrhea, herpes simplex and human papillomavirus.
Study finds that routine screening reduces anal cancer rate among people with HIV.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
Keytruda may prolong survival compared with standard therapy.
I’ve got a proper measuring tool—and a good reason to use it.
More widespread vaccination could reduce cervical, anal, oral and other cancers caused by human papillomavirus.
Abnormal anal screening results are common, but they often do not to lead to invasive cancer.
This malignancy, caused by human papillomavirus (HPV), can be prevented with a vaccine.
The vaccine is safe and effective against cancer-causing strains of HPV, and yet anti-vaccination misinformation campaigns have taken hold.
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk.
Men who have sex with men are at higher risk for the disease, which is driven by human papillomavirus.
Half of adolescents remain unprotected against virus that causes anal, cervical and oral cancer.
Having both chlamydia and high-risk HPV16 dramatically increases the risk of anal precancer.
This $14 million research project aims to find out. Here’s why it’s based in Miami.
Widespread vaccination could potentially eliminate cervical, anal, oral and other HPV-related cancers.
People living with HIV are also facing cancer as they age.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.